⌘K
Loading ticker…
As of 2026-08-26, Tandem Diabetes Care, Inc. (TNDM) has a 3-month relative strength percentile of 93 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 50.1 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.4%, relative volume 0.50×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TNDM is held by 30 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $6M notional. Top 3 carry $16M.
Held by 68 ETFs · $311M across latest filings · largest weight 1.51% (XHE).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.03% | $6M | −0.02 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $6M | −0.02 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.07% | $4M | −0.04 pp |
| VHTVanguard Health Care ETF | 0.02% | $4M | — |
| VIOVVanguard S&P Small-Cap 600 Value ETF |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.06% |
| $1M |
| −0.04 pp |
| VTWG | 0.06% | $1M | −0.04 pp |
| ESML | 0.04% | $1M | −0.02 pp |
| GSSC | 0.09% | $934K | −0.05 pp |
| RWJ | 0.05% | $876K | −0.03 pp |
| PSCH | 0.62% | $817K | −0.40 pp |
Showing 10 of 30 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TNDM Jan avg: -9.73% median: -9.44% win: 25% σ: 10.54% n: 4 2022-04-12 → 2026-07-31 | TNDM Feb avg: -2.06% median: 2.41% win: 50% σ: 30.38% n: 4 2022-04-12 → 2026-07-31 | TNDM Mar avg: 2.13% median: -0.11% win: 50% σ: 25.90% n: 4 2022-04-12 → 2026-07-31 | TNDM Apr avg: -5.51% median: -2.54% win: 40% σ: 9.43% n: 5 2022-04-12 → 2026-07-31 | TNDM May avg: -3.67% median: -11.91% win: 40% σ: 31.61% n: 5 2022-04-12 → 2026-07-31 | TNDM Jun avg: -11.67% median: -12.27% win: 0% σ: 6.45% n: 5 2022-04-12 → 2026-07-31 | TNDM Jul avg: 11.75% median: 11.86% win: 60% σ: 24.65% n: 5 2022-04-12 → 2026-07-31 | TNDM Aug avg: -13.66% median: -20.68% win: 25% σ: 21.43% n: 4 2022-04-12 → 2026-07-31 (current) | TNDM Sep avg: -6.23% median: -2.73% win: 25% σ: 12.40% n: 4 2022-04-12 → 2026-07-31 | TNDM Oct avg: -2.52% median: -0.69% win: 50% σ: 22.11% n: 4 2022-04-12 → 2026-07-31 | TNDM Nov avg: 9.90% median: 7.32% win: 50% σ: 31.83% n: 4 2022-04-12 → 2026-07-31 | TNDM Dec avg: 18.81% median: 12.25% win: 100% σ: 19.08% n: 4 2022-04-12 → 2026-07-31 |